Notice2025-10468
Joint Biomedical Laboratory and Clinical Science (BL/CS) Research and Development Services Scientific Merit Review Board, Federal Register Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 10, 2025
Issuing agencies
Veterans Affairs Department
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 110 (Tuesday, June 10, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 110 (Tuesday, June 10, 2025)]
[Notices]
[Page 24490]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-10468]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Joint Biomedical Laboratory and Clinical Science (BL/CS) Research
and Development Services Scientific Merit Review Board, Federal
Register Notice of Meeting
The Department of Veterans Affairs (VA) gives notice under the
Federal Advisory Committee Act, 5 U.S.C. 10, that a meeting of the
Joint Biomedical Laboratory Research and Development (BLR&D) and
Clinical Science Research and Development (CSR&D) Services Scientific
Merit Review Board will be held July 8, 2025, from 3-5 p.m. EST, via
Microsoft Teams. The meeting will be partially closed to the public,
with an open portion from 3-3:30 p.m. The closed portion, from 3:30-5
p.m., will be used for scientific review and discussion, examination
of, and reference to the research applications. Discussions will
involve staff and consultant critiques of research proposals.
Discussions will also cover the scientific merit of each proposal and
the qualifications of the personnel conducting the studies, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy. Additionally, premature disclosure of research
information could significantly obstruct implementation of proposed
agency action regarding the research proposals. As provided by Public
Law 92-463 subsection 10(d), and amended by Public Law 94-409, closing
the committee meeting is in accordance with Title 5 U.S.C. 552b(c)(6)
and (9)(B).
The objective of the Board is to provide for the fair and equitable
selection of the most meritorious research projects for support by VA
research funds and to offer advice for research program officials on
program priorities and policies. The ultimate objective of the Board is
to ensure the high quality and mission relevance of VA's legislatively
mandated BL/CS Research and Development programs.
Board members will advise the Directors of the BL/CS Research
Services, as well as the Acting Chief Research and Development Officer,
on the scientific and technical merit, mission relevance, and
protection of human subjects of the proposals submitted to BL/CS. The
Board does not consider grants, contracts, or other forms of extramural
research.
Members of the public may attend the open portion of the meeting
from 3-3:30 p.m. EST, via Microsoft Teams (in listen-only mode, as the
time limited agenda does not allow for public comment or
presentations). To attend the open portion of the meeting, the public
may dial the Microsoft Teams phone number (1-872-701-0185) and enter
the meeting access code (513 797 246#).
Written comments from members of the public should be sent to
Michael R. Burgio, Ph.D., Designated Federal Officer, Advisory
Committee Management Office, 811 Vermont Avenue NW, Room 4342A,
Washington, DC 20006, or to <a href="/cdn-cgi/l/email-protection#511c38323930343d7f13242336383e1127307f363e27"><span class="__cf_email__" data-cfemail="4c01252f242d2920620e393e2b25230c3a2d622b233a">[email protected]</span></a>, at least five days
before the meeting. The written public comments will be shared with the
Board members. The public may not attend the closed portion of the
meeting, as disclosure of research information could significantly
obstruct implementation of proposed agency action regarding the
research proposals (per Pub. L. 92-463 subsection 10(d) and amended by
Pub. L. 94-409, closing the meeting is in accordance with Title 5
U.S.C. 552b(c)(6) and (9)(B).
Dated: June 5, 2025.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2025-10468 Filed 6-9-25; 8:45 am]
BILLING CODE 8320-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 10, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.